The shares of Traws Pharma (NASDAQ:GRASS) soared 24% in after-market trading Friday on encouraging results from a Phase 1 study of the company’s drug Tivoxavir Marboxil in the treatment of H5N1 bird flu.
The study showed a single dose of
The shares of Traws Pharma (NASDAQ:GRASS) soared 24% in after-market trading Friday on encouraging results from a Phase 1 study of the company’s drug Tivoxavir Marboxil in the treatment of H5N1 bird flu.
The study showed a single dose of
Following these transactions, Gilson held 9,582 shares of Arcellx common stock. Sales include broker-assisted transactions to cover tax obligations associated with the vesting of restricted stock units. The company maintains…
Rumble Announces Cloud Agreement with Government of El Salvador Source link